Arcturus Therapeutics Q1 EPS $(1.00) Beats $(1.19) Estimate, Sales $38.01M Beat $17.54M Estimate
Arcturus Therapeutics Q1 EPS $(1.00) Beats $(1.19) Estimate, Sales $38.01M Beat $17.54M Estimate
Arcturus Therapeutics第一季度每股收益美元（1.00美元）超过预期（1.19美元），销售额3,801万美元超过预期的1754万美元
Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(1.00) per share which beat the analyst consensus estimate of $(1.19) by 15.97 percent. This is a 153.48 percent decrease over earnings of $1.87 per share from the same period last year. The company reported quarterly sales of $38.01 million which beat the analyst consensus estimate of $17.54 million by 116.72 percent. This is a 52.65 percent decrease over sales of $80.28 million the same period last year.
Arcturus Therapeutics（纳斯达克股票代码：ARCT）公布的季度亏损为每股1.00美元，比分析师共识估计的美元（1.19美元）高出15.97％。与去年同期的每股收益1.87美元相比，下降了153.48％。该公司公布的季度销售额为3,801万美元，比分析师普遍预期的1754万美元高出116.72％。这比去年同期的8,028万美元的销售额下降了52.65％。